Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 22, 2021 08:00 ET | Source: Decibel Therapeutics, Inc.

Decibel Therapeutics Added to Russell 2000 Index

BOSTON, March 22, 2021 (GLOBE NEWSWIRE) -- Decibel Therapeutics (Nasdaq: DBTX) (“Decibel”), a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments...
March 04, 2021 08:00 ET | Source: Decibel Therapeutics, Inc.

Decibel Therapeutics to Present at the Barclays Global Healthcare Conference

BOSTON, March 04, 2021 (GLOBE NEWSWIRE) -- Decibel Therapeutics (Nasdaq: DBTX), a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments to restore...
February 24, 2021 07:00 ET | Source: Decibel Therapeutics, Inc.

Decibel Therapeutics Presents Promising Preclinical Findings on DB-OTO, Gene Therapy Product Candidate Designed to Provide Hearing to Individuals with Otoferlin Mutations

BOSTON, Feb. 24, 2021 (GLOBE NEWSWIRE) -- Decibel Therapeutics (Nasdaq: DBTX), a clinical-stage company developing treatments to restore and improve hearing and balance, presented preclinical data...
February 19, 2021 07:00 ET | Source: Decibel Therapeutics, Inc.

Decibel Therapeutics to Present at the 44th Annual Association for Research in Otolaryngology (ARO) Conference

BOSTON, Feb. 19, 2021 (GLOBE NEWSWIRE) -- Decibel Therapeutics (Nasdaq: DBTX), a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments to restore and...
February 11, 2021 21:51 ET | Source: Decibel Therapeutics, Inc.

Decibel Therapeutics Announces Pricing of Initial Public Offering

BOSTON, Feb. 11, 2021 (GLOBE NEWSWIRE) -- Decibel Therapeutics (Nasdaq: DBTX), a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments to restore and...

keyboard_arrow_left Previous Page